Henry Schein, Inc. (HSIC) — ESG & Values Scores

Environment story

Henry Schein discloses minimal environmental data in its 10-K filing. No Scope 1, Scope 2, or Scope 3 emissions figures are reported, and no net-zero target year is disclosed. The company mentions AI datacenter expansion and increased technology deployment without offsetting decarbonization commitments. No evidence of renewable energy procurement targets, carbon reduction initiatives, or resource-use controversies specific to operations. The absence of mandatory climate disclosures and verified emissions reductions places environmental governance below median standards for comparable distributors.

Criticisms on file

Undisclosed Environmental Footprint: No Scope 1, 2, or 3 emissions data provided in Form 10-K; no net-zero commitment or climate target disclosed.
Source: HSIC 10-K (2025 fiscal year), Risk Factors and MD&A sections – environmental disclosures absent.
Supply Chain Sustainability Risk: 10-K acknowledges dependence on third-party suppliers for significant product volume (top 10 suppliers = 24% of purchases) without supply-chain environmental audit or diversity standards disclosed.
Source: HSIC 10-K Item 1A, Risk Factors – 'Dependence on Third Parties for Manufacture/Supply.'

Disclosed initiatives

CSRD Compliance Preparation

Company notes it is subject to EU Directive 2022/2464 (CSRD) requiring sustainability reporting on material financial and environmental/social impacts; Omnibus Directive delays implementation to 2025–2026.

Compliance burden increases; no verified emissions-reduction pathway disclosed.
AI Technology Expansion

10-K states company is increasing use of AI in practice management systems, cloud platforms, and patient data applications.

AI deployment may increase Scope 2 and Scope 3 datacenter emissions; no mitigation strategy articulated.

Social story

Henry Schein demonstrates moderate social performance. The company employs >25,000 people globally (~14% unionized); CEO tenure is 37 years (Stanley Bergman, retiring March 2026). CEO-to-worker pay ratio is not disclosed; diversity in executive leadership shows female representation (Christine Sheehy as CHRO since Nov 2024, Kelly Murphy as General Counsel since 2021) but male-dominated C-suite (8 named executives, 2 women). The company invests in employee ERGs, culture surveys, and wellness programs. Supply-chain labor audits are not explicitly described. Union standing is neutral (no NLRB complaints or strikes mentioned); ~14% workforce under collective bargaining. Turnover rate undisclosed. Leadership diversity below stated 30% threshold at executive-officer level (~25%).

Criticisms on file

Executive Leadership Diversity Below Threshold: Only 2 of 8 named executives are women (~25%), falling short of 30% diversity target.
Source: HSIC 10-K, 'Information about Executive Officers' and 'Other Executive Management' sections (Feb 24, 2026 roster).
CEO-to-Worker Pay Ratio Undisclosed: No CEO compensation-to-median-worker ratio provided; unable to assess pay equity compliance.
Source: HSIC 10-K – no CEO-to-worker pay ratio disclosed in executive compensation or proxy sections.
Supply-Chain Labor Rights Not Detailed: 10-K acknowledges supply-chain dependence but does not describe labor audits, conflict-minerals policy, or human-rights certification for third-party manufacturers.
Source: HSIC 10-K Item 1A, Risk Factors – 'Dependence on Third Parties' and 'Sales of Corporate Brand Products' sections lack labor-compliance detail.

Disclosed initiatives

Employee Resource Groups (ERGs) and Functional Resource Groups (FRGs)

Company launched ERGs and FRGs to foster inclusion, belonging, and professional development; CEO directly engages in ERG programs; each ERG has a sponsor from Executive Management Committee and Board.

Supports employee engagement and inclusive culture; measured as 'top strength' in fourth consecutive Pulse Global Culture Survey (2025).
Culture Ambassador Program

Certified 100 additional TSMs (Team Schein Members) as mentors for new-hire onboarding during first 90 days.

Enhances retention and cultural integration; supports inclusive onboarding.
Leadership Development and Succession Planning

Launched HELIX Network for high-performing leaders; implemented Core Leadership Capabilities (CLCs) globally; Board receives periodic updates on talent and succession planning.

Strengthens leadership pipeline and retention of talent; supports diversity advancement.
Mental Wellness and Voluntary Programs

Mental Wellness Committee supported by CEO and Board; launched 'Intrinsic Motivation' campaign; partnership with American Foundation for Suicide Prevention; Steps for Suicide Prevention walking campaign.

Supports employee mental health and community engagement.
Compensation and Fair Pay Commitment

10-K states company compensates employees 'based on role, experience, and performance, consistent with fair pay practices and competitive outcomes.'

No pay-ratio or equity audit disclosed; commitment is qualitative, not verified.

Governance story

Henry Schein exhibits mixed governance: single-class share structure with no dual-class voting supermajority (positive). Board independence not explicitly disclosed in 10-K, but KKR partnership (January 2025) introduced two independent directors (Max Lin, William K. Daniel), suggesting compliance with >75% threshold. Stanley Bergman served as Chairman/CEO for 37 years until March 1, 2026 (succession risk mitigated by appointment of Frederick M. Lowery as new CEO on March 2, 2026). Lobbying spend not disclosed. No active antitrust proceedings mentioned; October 2023 cybersecurity breach caused material disruption and $60M insurance claim + significant remediation costs. SEC/regulatory enforcement history not flagged in 10-K. KKR strategic investment (19.9% beneficial ownership limit post-amendment) introduces governance complexity but no evidence of activist suppression.

Criticisms on file

Prolonged CEO-Chairman Concentration: Stanley M. Bergman served as Chairman/CEO for 37 years (1989–2026); elevated succession risk and limited board independence during tenure.
Source: HSIC 10-K, 'Information about Executive Officers' and 'Recent Developments – Chief Executive Officer' sections.
October 2023 Cybersecurity Breach: Material incident affecting North American and European dental/medical distribution; disrupted operations, adversely impacted Q4 2023 and residual 2024 results; significant remediation costs and insurance claims.
Source: HSIC 10-K Item 1A, Risk Factors – 'Security Risks' and MD&A – 'Recent Developments – Cyber Incident' sections; cyber incident confirmed as major business disruption.
KKR Strategic Partnership Governance Complexity: KKR investment ($250M, ~5% initial stake, up to 19.9% post-amendment) introduces potential conflicts of interest with third parties and competitors in which KKR invests; standstill provisions and extension elections create management uncertainty.
Source: HSIC 10-K Item 1A, Risk Factors – 'Our business could be affected by the Strategic Partnership Agreement with KKR' and MD&A – 'Recent Developments.'
Board Independence Percentage Not Disclosed: 10-K does not explicitly state board independence percentage; cannot verify compliance with >75% threshold or assess potential conflicts.
Source: HSIC 10-K – board independence metrics absent from governance sections; proxy statement review recommended for full disclosure.

Disclosed initiatives

Board Refresh via KKR Partnership

Strategic Partnership Agreement (Jan 2025) with KKR brought two independent directors to Board (Max Lin, William K. Daniel); KKR entitled to up to 19.9% beneficial ownership (post-Nov 2025 amendment).

Enhances board independence and governance oversight; standstill and extension provisions extend through 2026–2027.
CEO Succession Planning

Stanley M. Bergman retired as CEO on March 1, 2026; Frederick M. Lowery appointed as new CEO effective March 2, 2026; Bergman remains Chairman.

Addresses long-tenure concentration risk; enables leadership continuity.
Cybersecurity Defense Enhancement Post-2023 Incident

Company states it has 'spent and plan to expend in the future, additional resources to continue to protect against or address problems caused by business interruptions and data security breaches'; multiple layers of security monitoring and third-party testing.

Mitigates recurrence of October 2023 breach; ongoing investment in IT controls and vendor security.
Nominating and Governance Committee Oversight

Board Nominating and Governance Committee oversees human capital and ESG matters; Compensation Committee also plays role in environmental, social, and governance matters.

Formalizes governance of ESG topics at board level; periodic reporting to Board on talent and succession.

These are Missionomics' own editorial scores — directional signals built from disclosed facts under a published method, not certifications or definitive ratings of Henry Schein, Inc.. Coverage and confidence vary by data point, and figures can lag real-world changes. Read the full Methodology for sourcing, scoring, and correction details — or open Henry Schein, Inc. in the app for interactive charts and portfolio building.

More in Healthcare

Eli Lilly and Company (LLY) Johnson & Johnson (JNJ) AbbVie Inc. (ABBV) UnitedHealth Group Incorporated (UNH) Merck & Co., Inc. (MRK) Thermo Fisher Scientific Inc. (TMO)